1F0N - Header Asymmetric Unit

HEADER TRANSFERASE 16-MAY-00 1F0N

TITLE MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85B

COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIGEN 85B; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 EXPRESSION_SYSTEM: MYCOBACTERIUM SMEGMATIS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1772; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PSMT3

KEYWDS MYCOLYL TRANSFERASE; 30KDA SECRETORY PROTEIN; ANTIGEN 85B, KEYWDS 2 STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, TB KEYWDS 3 STRUCTURAL GENOMICS CONSORTIUM, TBSGC

EXPDTA X-RAY DIFFRACTION

AUTHOR D.H.ANDERSON,G.HARTH,M.A.HORWITZ,D.EISENBERG,TB STRUCTURAL AUTHOR 2 GENOMICS CONSORTIUM (TBSGC)

REVDAT 4 24-FEB-09 1F0N 1 VERSN REVDAT 3 01-FEB-05 1F0N 1 AUTHOR KEYWDS REMARK REVDAT 2 28-MAR-01 1F0N 1 JRNL REVDAT 1 24-JAN-01 1F0N 0

JRNL AUTH D.H.ANDERSON,G.HARTH,M.A.HORWITZ,D.EISENBERG JRNL TITL AN INTERFACIAL MECHANISM AND A CLASS OF INHIBITORS JRNL TITL 2 INFERRED FROM TWO CRYSTAL STRUCTURES OF THE JRNL TITL 3 MYCOBACTERIUM TUBERCULOSIS 30 KDA MAJOR SECRETORY JRNL TITL 4 PROTEIN (ANTIGEN 85B), A MYCOLYL TRANSFERASE. JRNL REF J.MOL.BIOL. V. 307 671 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11254389 JRNL DOI 10.1006/JMBI.2001.4461

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.R.RONNING,T.KLABUNDE,G.S.BESRA,V.D.VISSA, REMARK 1 AUTH 2 J.T.BELISLE,J.C.SACCHETTINI REMARK 1 TITL CRYSTAL STRUCTURE OF THE SECRETED FORM OF ANTIGEN REMARK 1 TITL 2 85C REVEALS POTENTIAL TARGETS FOR MYCOBACTERIAL REMARK 1 TITL 3 DRUGS AND VACCINES REMARK 1 REF NAT.STRUCT.BIOL. V. 7 141 2000 REMARK 1 REFN ISSN 1072-8368 REMARK 1 DOI 10.1038/72413

REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM (CCP4 UNIQUEIFY) REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.196 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.194 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1343 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 26529 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.190 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.188 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1222 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 24239 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4173 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 229 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2384.20 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2021.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 9593 REMARK 3 NUMBER OF RESTRAINTS : 9186 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.034 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.021 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.061 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.069 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.022 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.073 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER SPECIAL CASES: REMARK 3 2-METHYL-2,4-PENTANEDIOL (MPD) REMARK 3 IS RESTRAINED TO MATCH PDB CODE REMARK 3 3AL1; 2-(4-MORPHOLINO)- REMARK 3 ETHANESULFONIC ACID (MES) IS REMARK 3 RESTRAINED TO MATCH PDB CODE REMARK 3 3CHB. REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56

REMARK 4 REMARK 4 1F0N COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-MAY-00. REMARK 100 THE RCSB ID CODE IS RCSB011099.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26822 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.11200 REMARK 200 R SYM (I) : 0.11200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.18600 REMARK 200 R SYM FOR SHELL (I) : 0.18600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: ANTIGEN 85C, RONNING, ET AL. (2000) REMARK 200 NAT.STRUCT.BIOL. 7(2), 141-146. REMARK 200 REMARK 200 REMARK: USED APPROXIMATE E VALUES, NOT F VALUES IN AMORE.

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, MES, MPD, PH 6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 21K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.84800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 61.69600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 61.69600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.84800 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 583 LIES ON A SPECIAL POSITION.

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 1

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 3 N - CA - CB ANGL. DEV. = 12.4 DEGREES REMARK 500 ARG A 3 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG A 3 C - N - CA ANGL. DEV. = -16.2 DEGREES REMARK 500 ASP A 21 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 GLY A 29 C - N - CA ANGL. DEV. = 29.0 DEGREES REMARK 500 TYR A 37 CB - CG - CD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 TYR A 37 CB - CG - CD1 ANGL. DEV. = 3.6 DEGREES REMARK 500 TYR A 48 CG - CD1 - CE1 ANGL. DEV. = -5.0 DEGREES REMARK 500 SER A 67 N - CA - CB ANGL. DEV. = 9.3 DEGREES REMARK 500 PHE A 78 O - C - N ANGL. DEV. = -10.3 DEGREES REMARK 500 TYR A 79 C - N - CA ANGL. DEV. = 15.8 DEGREES REMARK 500 TYR A 145 CB - CG - CD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 TRP A 180 CD1 - NE1 - CE2 ANGL. DEV. = 6.6 DEGREES REMARK 500 TYR A 210 CB - CG - CD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TYR A 210 CB - CG - CD1 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG A 234 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 PHE A 240 CB - CG - CD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 PHE A 240 CB - CG - CD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 TYR A 244 CB - CG - CD2 ANGL. DEV. = -5.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 43 39.44 -96.49 REMARK 500 PRO A 56 46.02 -92.84 REMARK 500 SER A 76 15.54 57.27 REMARK 500 SER A 103 -60.46 -143.04 REMARK 500 SER A 126 -127.90 59.51 REMARK 500 ASN A 217 -158.14 -124.25 REMARK 500 HIS A 250 21.96 -153.26 REMARK 500 PRO A 258 30.05 -75.71 REMARK 500 ALA A 284 -140.73 -73.12 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 1101 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1001 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1002 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1003

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F0P RELATED DB: PDB REMARK 900 1F0P IS ANTIGEN 85B, ISOMORPHOUS, WITH TREHALOSE. REMARK 900 RELATED ID: 1DQZ RELATED DB: PDB REMARK 900 1DQZ IS ANTIGEN 85C REMARK 900 RELATED ID: 1DQY RELATED DB: PDB REMARK 900 1DQY IS ANTIGEN 85C WITH DIETHYL PHOSPHATE INHIBITOR. REMARK 900 RELATED ID: RV1886C RELATED DB: TARGETDB

DBREF 1F0N A 1 285 UNP P31952 A85B_MYCTU 41 325

SEQRES 1 A 285 PHE SER ARG PRO GLY LEU PRO VAL GLU TYR LEU GLN VAL SEQRES 2 A 285 PRO SER PRO SER MET GLY ARG ASP ILE LYS VAL GLN PHE SEQRES 3 A 285 GLN SER GLY GLY ASN ASN SER PRO ALA VAL TYR LEU LEU SEQRES 4 A 285 ASP GLY LEU ARG ALA GLN ASP ASP TYR ASN GLY TRP ASP SEQRES 5 A 285 ILE ASN THR PRO ALA PHE GLU TRP TYR TYR GLN SER GLY SEQRES 6 A 285 LEU SER ILE VAL MET PRO VAL GLY GLY GLN SER SER PHE SEQRES 7 A 285 TYR SER ASP TRP TYR SER PRO ALA CYS GLY LYS ALA GLY SEQRES 8 A 285 CYS GLN THR TYR LYS TRP GLU THR PHE LEU THR SER GLU SEQRES 9 A 285 LEU PRO GLN TRP LEU SER ALA ASN ARG ALA VAL LYS PRO SEQRES 10 A 285 THR GLY SER ALA ALA ILE GLY LEU SER MET ALA GLY SER SEQRES 11 A 285 SER ALA MET ILE LEU ALA ALA TYR HIS PRO GLN GLN PHE SEQRES 12 A 285 ILE TYR ALA GLY SER LEU SER ALA LEU LEU ASP PRO SER SEQRES 13 A 285 GLN GLY MET GLY PRO SER LEU ILE GLY LEU ALA MET GLY SEQRES 14 A 285 ASP ALA GLY GLY TYR LYS ALA ALA ASP MET TRP GLY PRO SEQRES 15 A 285 SER SER ASP PRO ALA TRP GLU ARG ASN ASP PRO THR GLN SEQRES 16 A 285 GLN ILE PRO LYS LEU VAL ALA ASN ASN THR ARG LEU TRP SEQRES 17 A 285 VAL TYR CYS GLY ASN GLY THR PRO ASN GLU LEU GLY GLY SEQRES 18 A 285 ALA ASN ILE PRO ALA GLU PHE LEU GLU ASN PHE VAL ARG SEQRES 19 A 285 SER SER ASN LEU LYS PHE GLN ASP ALA TYR ASN ALA ALA SEQRES 20 A 285 GLY GLY HIS ASN ALA VAL PHE ASN PHE PRO PRO ASN GLY SEQRES 21 A 285 THR HIS SER TRP GLU TYR TRP GLY ALA GLN LEU ASN ALA SEQRES 22 A 285 MET LYS GLY ASP LEU GLN SER SER LEU GLY ALA GLY

HET MES A1101 12 HET MPD A1001 8 HET MPD A1002 8 HET MPD A1003 8

HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL

FORMUL 2 MES C6 H13 N O4 S FORMUL 3 MPD 3(C6 H14 O2) FORMUL 6 HOH *205(H2 O)

HELIX 1 1 ASN A 49 THR A 55 1 7 HELIX 2 2 PRO A 56 TYR A 62 1 7 HELIX 3 3 LYS A 96 SER A 103 1 8 HELIX 4 4 SER A 103 ALA A 114 1 12 HELIX 5 5 SER A 126 HIS A 139 1 14 HELIX 6 6 MET A 159 ALA A 171 1 13 HELIX 7 7 LYS A 175 GLY A 181 1 7 HELIX 8 8 PRO A 186 ASN A 191 1 6 HELIX 9 9 GLN A 196 ASN A 203 1 8 HELIX 10 10 ASN A 223 ALA A 247 1 25 HELIX 11 11 SER A 263 GLY A 283 1 21

SHEET 1 A 8 VAL A 8 SER A 15 0 SHEET 2 A 8 ARG A 20 GLN A 27 -1 O ARG A 20 N SER A 15 SHEET 3 A 8 SER A 67 PRO A 71 -1 N ILE A 68 O GLN A 27 SHEET 4 A 8 ALA A 35 LEU A 39 1 O VAL A 36 N VAL A 69 SHEET 5 A 8 SER A 120 LEU A 125 1 O ALA A 121 N TYR A 37 SHEET 6 A 8 PHE A 143 LEU A 149 1 N ILE A 144 O SER A 120 SHEET 7 A 8 ARG A 206 TYR A 210 1 O ARG A 206 N ALA A 146 SHEET 8 A 8 ALA A 252 ASN A 255 1 O VAL A 253 N VAL A 209 SHEET 1 B 2 ALA A 86 GLY A 88 0 SHEET 2 B 2 GLY A 91 GLN A 93 -1 O GLY A 91 N GLY A 88

SSBOND 1 CYS A 87 CYS A 92 1555 1555 2.01

SITE 1 AC1 4 ARG A 206 HIS A 250 ASN A 251 HOH A 556 SITE 1 AC2 3 MET A 127 LEU A 163 HOH A 455 SITE 1 AC3 6 ARG A 3 ASP A 52 ILE A 53 ALA A 177 SITE 2 AC3 6 GLY A 181 PRO A 182 SITE 1 AC4 6 HIS A 139 PRO A 140 GLN A 141 GLN A 142 SITE 2 AC4 6 HOH A 504 HOH A 565

CRYST1 73.210 73.210 92.544 90.00 90.00 120.00 P 31 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.013659 0.007886 0.000000 0.00000

SCALE2 0.000000 0.015772 0.000000 0.00000

SCALE3 0.000000 0.000000 0.010806 0.00000